ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation

Oncogene

Volumn 24, Issue 54, 2005, Pages 8051-8060

  Takada, Hisashi ^a,b,c   Imoto, Issei ^a,b   Tsuda, Hitoshi ^b,d   Nakanishi, Yukihiro ^e   Ichikura, Takashi ^d   Mochizuki, Hidetaka ^d   Mitsufuji, Shoji ^c   Hosoda, Fumie ^b,e   Hirohashi, Setsuo ^e   Ohki, Misao ^e   Inazawa, Johji ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

ADAM23; CGH array; Gastric cancer; Homozygous deletion; Methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA;

ARTICLE; CARCINOGENESIS; CELL COUNT; CELL LINE; CPG ISLAND; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENETICS; GENOMICS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; SCREENING; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADAM PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEIC ACID HYBRIDIZATION; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS;

EID: 28544438198     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208952     Document Type: Article

References (32)

1. Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T and Tahara E. (1996). Jpn J Cancer Res., 87, 824-830.
2. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, Huebner K, Edmonds P and Croce CM. (2004). Clin Cancer Res., 10, 3053-3058.
3. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP. (1998). Adv Cancer Res., 72, 141-196.
4. Cal S, Freije JM, Lopez JM, Takada Y and Lopez-Otin C. (2000). Mol Biol Cell 11, 1457-1469.
5. Carl-McGrath S, Lendeckel U, Ebert M, Roessner A and Rocken C. (2005). Int J Oncol., 26, 17-24.
6. Costa FF, Verbisck NV, Salim AC, Ierardi DF, Pires LC, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares F, Simpson AJ and Camargo AA. (2004). Oncogene, 23, 1481-1488.
7. Feakins RM, Nickols CD, Bidd H and Walton SJ. (2003). Hum Pathol., 34, 1276-1282.
8. Fukuda Y, Kurihara N, Imoto I, Yasui K, Yoshida M, Yanagihara K, Park JG, Nakamura Y and Inazawa J. (2000). Genes Chromosomes Cancer, 29, 315-324.
9. Gorringe KL, Boussioutas A, Bowtell DD and Melbourne Gastric Cancer Group. Peter Mac Micro Array Facility. (2005). Genes Chromosomes Cancer, 42, 247-259.
10. Huiping C, Kristjansdottir S, Bergthorsson JT, Jonasson JG, Magnusson J, Egilsson V and Ingvarsson S. (2002). Eur J Cancer, 38, 728-735.
11. Imoto I, Yuki Y, Sonoda I, Ito T, Shimada Y, Imamura M and Inazawa J. (2003). Cancer Res., 63, 5691-5696.
12. Inazawa J, Inoue J and Imoto I. (2004). Cancer Sci., 95, 559-563.
13. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH and Kim JS. (2003). Am J Pathol., 163, 1551-1556.
14. Kimura Y, Noguchi T, Kawahara K, Kashima K, Daa T and Yokoyama S. (2004). Mod Pathol., 17, 1328-1337.
15. Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E and Okada Y. (2004). Am J Pathol., 165, 1743-1753.
16. Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim SH and Noh SM. (2000). Cancer Genet Cytogenet., 117, 97-103.
17. McCulloch DR, Akl P, Samaratunga H, Herington AC and Odorico DM. (2004). Clin Cancer Res., 10, 314-323.
18. Noguchi M, Furuya S, Takeuchi T and Hirohashi S. (1997). Pathol Int, 47, 685-691.
19. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N and Duffy MJ. (2003). Int J Cancer, 105, 754-761.
20. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y and Hattori T. (2003). J Pathol., 201, 439-450.
21. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T and Inazawa J. (1999). Genes Chromosomes Cancer, 24, 299-305.
22. Seals DF and Courtneidge SA. (2003). Genes Dev., 17, 7-30.
23. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H and Matsuura N. (2004). Cancer Res., 64, 4190-4196.
24. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG. (2001). Nat Genet., 29, 263-264.
25. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S and Inazawa J. (2004). Cancer Res, 64, 3741-3747.
26. Tahara E. (1995). World J Surg., 19, 484-490.
27. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T and Inazawa J. (2005). Cancer Sci., 96, 100-110.
28. Tanabe C, Aoyagi K, Sakiyama T, Kohno T, Yanagitani N, Akimoto S, Sakamoto M, Sakamoto H, Yokota J, Ohki M, Terada M, Yoshida T and Sasaki H. (2003). Genes Chromosomes Cancer, 38, 168-176.
29. Tay ST, Leong SH, Yu K, Aggarwal A, Tan SY, Lee CH, Wong K, Visvanathan J, Lim Dennis, Wong WK, Soo KC, Kon OL and Tan P. (2003). Cancer Res., 63, 3309-3316.
30. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SG, Albertson D and Meijer GA. (2004). Cell Oncol., 26, 307-317.
31. Wu E, Croucher PI and McKie N. (1997). Biochem Biophys Res Commun., 235, 437-442.
32. Yuki Y, Imoto I, Imaizumi M, Hibi S, Kaneko Y, Amagasa T and Inazawa J. (2004). Cancer Sci., 95, 503-507.